Altai Protocol Library
1041 protocols and counting
All protocols with references and links
All protocols reviewed by a Medical Oncologist/Hematologist
All protocols in major guidelines included
Ability to create your own protocols
New Drug: Sacituzumab govitecan in patients (Pts) with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer
New Drug: Sacituzumab govitecan in patients (Pts) with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer | |
---|---|
Study: |
|
Efficacy: |
|
Safety: |
|
JCO, 2022 (40):17 LBA1001-LBA1001 Rugo S-H et al. ¨ Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer. ¨ http://doi.org/10.1200/JCO.2022.40.17_suppl.LBA1001 Reviewed by Elvin CHALABİYEV, MD on FEB 24, 2023 |
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.